Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Product: Rapilysin. Active Ingredient(s): Reteplase 10U. Dosage Form: Powder for injection. NZ Sponsor: Roche Products (New Zealand) Limited. Manufacturer(s): Roche Diagnostics GmbH, Mannheim, Germany. Dated this 30th day of September 1999. S. S. JESSAMINE, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).